References
- Vane J. R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature (New Biol.), 1971, 231: 232–5.
- Karim S. M.M., Trussell R.R., Patel R. C. Hillier K. Response of pregnant human uterus to prostaglandin F2a-induction of labour. Br Med J., 1968, iv: 621–3.
- Embrey M. P. The effect of prostaglandins on the pregnant human uterus. J Obst Gynaecol Brit Commonw., 1969, 76: 783–9.
- Hillier K., Wallis R. M. Prostaglandins, steroids and the human cervix. In: The cervix inpregnancy and labour. Ed. D.A. Elwood and A.B.M. Anderson, p. 144–62, Churchill Livingstone, Edinburgh.
- Mackenzie I. Z., Davies A. J., Embrey M. P. Fetal death in utero managed with vaginal prostaglandin E2gel. Br Med J., 1979, i: 17645.
- Southern E. M., Gutknecht G. D., Mohberg N.R., Edelman D. A. Vaginal prostaglandin E2 in the management of fetal intrauterine death. Br J Obstet Gynaecol. 1978, 85: 437–41.
- Tagaki S., Yoshida T. Togo Y. et al. The effects of intramyometrial injection of prostaglandin F2α on severe post partum hemorrhage. Prostaglandins. 1976, 12: 565–79.
- Thiery M. Exogene prostaglandines in het na geboortelijdvak en vroege postpartum. Tijdschr v Geneesk., 1981, 37: 1135–43.
- Brenner P. F., Lumkin M. E. Ballard C., Mischell D. R. Termination of early gestation with intramuscular 15 (S), 15-methyl prostaglandin F2(t Contraception. 1975, 11: 279–87.
- Karim S. M.M., Ratnam S. S. Termination of pregnancy with vaginal administration of 16, 16 dimethyl prostaglandin E2 p-benzaldehyde semicarbazone ester. Br J Obstet Gynaecol., 1977, 84: 135–7.
- Karim S.M.M., Ratham S.S., Ilancheran A. Menstrual induction with vaginal administration of 16, 16 dimethyl trans2 PGE methyl ester (ONO 802). Prostaglandins. 1977, 14: 615–6.
- Embrey M. P. Prostaglandins in human reproduction. Br Med J. 1981, iv: 1563–6.
- Mackenzie I. Z., Embrey M. P. Cervical ripening with intravaginal prostaglandin E2 gel upon subsequent labour. Br J Obstet Gynae col., 1978, 85: 657–61.
- Shepherd J., Pearce J.M.F., Sims C.D. Induction of labour using prostaglandin E2 pessaries. Br Med J., 1979, ii, 108–10.
- Blake D.A., Niebyl J.R., White R.D. et al Treatment of premature labor with indomethacin. In: Advances in Prostaglandin and Thromboxane Research. Ed. B. Samuelsson, P. W. Ramwell and R. Paoletti, vol. 8, p. 1465–7., Raven Press, New York, 1980.
- Anderson A.B.M., Fraser I.S., Haynes P.J., Turnbull A.C. Trial of prostaglandin synthetase inhibitors in primary dysmenorrhoea. Lancet. 1978, i: 345–8.
- Friedman W. F. Hirschklan M. J., Printz M. P., Pithik P.T., Kirkpatrick S. E. Pharmacologic closure of patent ductus arteriosus in the premature infant. jV Engl J Med., 1976, 295: 256–9.
- Heymann M. A., Rudolph A. M. Silverman N. H. Closure of the ductus arteriosus in prema ture infants by inhibition of prostaglandin synthesis. N Engl J Med., 1976, 295: 530–3.
- Schleman M. M., Casta A., Mongkolsmai C., Black I. F.S. Prostaglandin E, in the neonate with heart disease. In: Advances in Prostaglandin and Thromboxane Research. Ed. B. Samuelsson, P. W. Ramwell and R. Paoletti, vol. 7, p. 879–81, Raven Press, New York, I. 980.
- Sczeklik A., Skawinski S. Gluszko P., Nizankowski R., Szczeklik J. Gryglewski R. Successfull therapy of advanced arteriosclerosis obliterans with prostacyclin. Lancet. 1979, i: 11114.
- Carlson L. A., Olsson A.G. Intravenous prostaglandin E, in severe peripheral vascular disease. Lancet. 1976, ii: 810.
- Clifford P. C., Martin M. F. R., Sheddon E. J., Kirby J. D. Baird R. N. Dieppe P. A. Treat ment of vasospastic disease with prostaglandin E,. Br Med J., 1980, iii: 1031–4.
- Dowd P. M., Kovacs I. B. Bland C.J.H. Kirby J. D. T. Effect of prostaglandins I2 and E2 on red cell deformability in patients with Raynaud’s phenomenon and systemic sclerosis. Br Med J. 1981, iii: 350.
- Watkins W. D., Peterson M. B. Crone R. K., Shannon D. C., Levine L. Prostacyclin and prostaglandin E, for severe idiopathic pulmonary artery hypertension. Lancet. 1980, i: 1083.
- Fidler J., Bennett M. J., De Swiet M. Ellis C., Lewis P. J. Treatment of pregnancy hypertension with prostacyclin. Lancet. 1980, ii: 31–2.
- Zusman R. M. Rubin R. H., Cato A. E., Cocchetto D. M., Crow J. W. Tolkoff-Rubin N. Hemodialysis using prostacyclin instead of heparin as the sole antithrombotic agent. N Engl J Med., 1981, 304: 934–9.
- Longmore D. B., Hoyle P. M. Gregory A. et al. Prostacyclin administration during cardiopulmonary bypass in man. Lancet. 1981, i: 800 1.
- Robert A. Cytoprotection by prostaglandins. Gastroenterology. 1979, 77: 761–807.
- Domschke S., Ruppin H. Domschke W. Prostaglandins and gastric cytoprotection in man. In: Stomach diseases-current status. Ed. Y. M. F. Van Maercke, F. M. J. Van Moer and P. A. R. Pelckmans, p; 33–7, Exerpta Medica, Amsterdam, 1981.
- Fung W. P., Karim S.M.M., Tye C. Y. Effect of 15 (R) 15-methyl prostaglandin E2 methyl ester on healing of gastric ulcers. Lancet. 1974, ii: 10.
- Gibinski K., Rybicka J., Mikos E., Nowak A. Double-blind clinical trial on gastroduodenal ulcer healing with prostaglandin E2 analogues. Gut. 1977, 18: 636.
- Cohen M. M. Mucosal cytoprotection by prostaglandin E2. Lancet. 1978, ii: 1253–4.
- Johannson C., Kolberg B., Nordemar R., Bergstrom S. Mucosal protection by prostaglandin E2. Lancet. 1979, i: 317.
- Sweatman W., Collier H. Effects of prostaglandins on human bronchial muscle. Nautre. 1968, 217: 69.
- Cuthbert M. Effect on resistance of prostaglandin E2 given by aerosol to healthy and asthmatic volunteers. Br Med J. 1969, iv: 723–7.
- Karim S. M.M., Adaikan P. G., Kottegoda S. R. Prostaglandins and human respiratory tract smooth muscle: structure activity relationship. In: Advances in Prostaglandin and Thromboxane Research. Ed. B. Samuelsson, P. W. Ramwell and R. Paoletti, vol. 7, p. 969–80, Raven Press, New York, 1980.